Showing 1 - 5 results of 5 for search 'Fernando Henao‑Carrasco', query time: 0.02s Refine Results
  1. 1
    Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial

    Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenal... by Carlos Jiménez-Cortegana, Pilar M. Sánchez-Martínez, Natalia Palazón-Carrión, Esteban Nogales-Fernández, Fernando Henao-Carrasco, Alejandro Martín García-Sancho, Antonio Rueda, Mariano Provencio, Luis de la Cruz-Merino, Víctor Sánchez-Margalet

    Published 2021-09-01
    Get full text
    Article
  2. 2
    Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy

    Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy by Miguel-Angel Berciano-Guerrero, Rocío Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra, Ismael Navas-Delgado, Antonio Rueda-Dominguez, Elisabeth Perez-Ruiz, Emilio Alba

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

    Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer by Natalia Palazón‑Carrión, Carlos Jiménez‑Cortegana, M. Luisa Sánchez‑León, Fernando Henao‑Carrasco, Esteban Nogales‑Fernández, Massimo Chiesa, Rosalía Caballero, Federico Rojo, María‑Adoración Nieto‑García, Víctor Sánchez‑Margalet, Luis de la Cruz‑Merino, the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)

    Published 2021-08-01
    Get full text
    Article
  4. 4
    Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

    Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer by Natalia Palazón-Carrión, Carlos Jiménez-Cortegana, M. Luisa Sánchez-León, Fernando Henao-Carrasco, Esteban Nogales-Fernández, Massimo Chiesa, Rosalía Caballero, Federico Rojo, María-Adoración Nieto-García, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)

    Published 2021-07-01
    Get full text
    Article
  5. 5
    Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study

    Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study by Luis de la Cruz-Merino, María Gion, Josefina Cruz-Jurado, Vanesa Quiroga, Raquel Andrés, Fernando Moreno, Jose L. Alonso-Romero, Manuel Ramos, Esther Holgado, Javier Cortés, Elena López-Miranda, Fernando Henao-Carrasco, Natalia Palazón-Carrión, Luz M. Rodríguez, Isaac Ceballos, Maribel Casas, Sara Benito, Massimo Chiesa, Susana Bezares, Rosalia Caballero, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet, Federico Rojo

    Published 2021-10-01
    Get full text
    Article

Search Tools: